Roche Holding prolongs Spark offer until May

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Roche Holding has decided to prolong its $4.3B offer for the US gene therapy company Spark Therapeutics until May 2, after the Swiss drugmaker got only 29.4% of specialist's shares in a deal originally due to complete on Wednesday.
Back to articles

Actual Topics

Subscribe to "Fundamental Analysis" feed

Souscrire
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.